ESI-MS characterisation of protein adducts of anticancer ruthenium(II)-arene PTA (RAPTA) complexes

Angela Casini, Guido Mastrobuoni, Wee Han Ang, Chiara Gabbiani, Giuseppe Pieraccini, Gloriano Moneti, Paul J. Dyson, Luigi Messori

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Abstract

(Chemical Equation Presented) Electrospray ionization mass spectrometry allows a rapid characterisation of the adducts formed between three novel anticancer ruthenium(II)-arene PTA compounds and horse heart cytochrome c or hen egg white lysozyme. Specific information on the nature of the protein-bound metallic fragments and the extent of protein metallation was readily obtained.

Original languageEnglish
Pages (from-to)631-635
Number of pages5
JournalChemMedChem
Volume2
Issue number5
DOIs
StatePublished - 14 May 2007
Externally publishedYes

Keywords

  • Anticancer drugs
  • Complexes
  • High-resolution ESIMS
  • Proteins
  • Ruthenium arene

Fingerprint

Dive into the research topics of 'ESI-MS characterisation of protein adducts of anticancer ruthenium(II)-arene PTA (RAPTA) complexes'. Together they form a unique fingerprint.

Cite this